Andes Virus (Orthohantavirus andesense)
conceptBiotech & Transhumanism
A deadly rodent-borne virus that usually needs close family contact to spread found a perfect new incubator: a cruise ship.
Who they are
Andes virus, a South American hantavirus carried by a pygmy rice rat in southern Argentina and Chile.
What they do
It's unusual because it can pass person to person, and it kills roughly 30-40% of people who get its lung-and-heart form.
How it works
Human spread needs close, prolonged contact (households, caregivers, health workers), seen in the 1996 El Bolson and 2018-19 Epuyen outbreaks. There's no approved vaccine, ribavirin doesn't help, and care is supportive. In April 2026 the MV Hondius cruise ship became the first known outbreak inside a confined commercial setting — shared cabins, dining halls, and recirculated air artificially recreated the close-contact conditions the virus needs.
Why it matters
It marks a new way this lethal virus can spread, while vaccine candidates sit waiting in the pipeline for a triggering event.
The engine's record — word for word
A South American hantavirus carried by the long-tailed pygmy rice rat (Oligoryzomys longicaudatus), native to southern Argentina and Chile. Unique among hantaviruses because it can spread from person to person — documented in the 1996 El Bolsón outbreak and the 2018-19 Epuyén super-spreader cluster — but transmission requires close, prolonged contact (households, family caregivers, healthcare workers). Case-fatality rate roughly 30-40% for the cardiopulmonary form. No approved vaccine; ribavirin doesn't work; treatment is supportive (oxygen, ventilation, ECMO in severe cases). Incubation 1-8 weeks. **Report #84:** the MV Hondius cluster (April 2026) is the first documented Andes-virus outbreak inside a confined commercial setting (cruise ship). The shared cabins, dining halls, and recirculated air of an expedition vessel artificially recreated the household-intimacy conditions Andes needs to spread — a new exposure paradigm. Existing vaccine candidates (ANDES-DNA Phase 1 trial completed; UTMB mRNA platform with successful animal data) sit in the pipeline waiting for a triggering event.
Follow the trail
Walk this on the live map →